Ian E McCutcheon
Overview
Explore the profile of Ian E McCutcheon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
2897
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faraj C, McCutcheon I, Gubbiotti M, Perni S, Gule-Monroe M, Akdemir K, et al.
J Neurooncol
. 2025 Mar;
PMID: 40055259
Purpose: Extra-central nervous system metastasis (ECM) from glioblastoma and other high-grade gliomas (HGGs) is exceedingly rare, likely due to central nervous system barriers and the short overall survival (OS) in...
2.
Gubbiotti M, McCutcheon I, Rao P, Genovese G, Wang L, Tarasov A, et al.
Acta Neuropathol Commun
. 2025 Jan;
13(1):12.
PMID: 39833894
Renal medullary carcinoma is a rare undifferentiated tumor of the kidney associated with sickle cell trait and characterized by INI1 (SMARCB1) loss. Although metastasis to lungs, lymph nodes, and bone...
3.
Tomczak K, Patel M, Bhalla A, Peterson C, Landers S, Callahan S, et al.
Mol Carcinog
. 2024 Nov;
64(1):44-56.
PMID: 39600120
Malignant peripheral nerve sheath tumor (MPNST) development is characterized by an altered DNA methylation landscape, which presents a promising area for developing MPNST-specific biomarkers for screening patients with NF1. Genome-wide...
4.
Faraj C, McCutcheon I, Gubbiotti M
Ann Diagn Pathol
. 2024 Nov;
74:152398.
PMID: 39549524
The nomenclature and classification of neuroendocrine tumors of the anterior pituitary have undergone significant change over the last few years. Despite the updated classification system as devised by the World...
5.
Dasgupta P, McCutcheon I, Slopis J
Can J Neurol Sci
. 2024 Oct;
:1.
PMID: 39358987
No abstract available.
6.
Faraj C, McCutcheon I, Schomer D, Aldape K, Quezado M, Abdullaev Z, et al.
J Neuropathol Exp Neurol
. 2024 Aug;
84(1):87-90.
PMID: 39088579
No abstract available.
7.
Saberian C, Milton D, Simon J, Amaria R, Diab A, McQuade J, et al.
Neurooncol Pract
. 2024 Jul;
11(4):452-463.
PMID: 39006528
Background: Melanoma leptomeningeal disease (LMD) has a poor prognosis. However, the management of patients with advanced melanoma has evolved with time, including those with LMD. We reviewed a large cohort...
8.
Ene C, Faraj C, Beckham T, Weinberg J, Andersen C, Haider A, et al.
Nat Commun
. 2024 May;
15(1):3728.
PMID: 38697991
With improvements in survival for patients with metastatic cancer, long-term local control of brain metastases has become an increasingly important clinical priority. While consensus guidelines recommend surgery followed by stereotactic...
9.
Glitza Oliva I, Ferguson S, Bassett Jr R, Foster A, John I, Hennegan T, et al.
Nat Med
. 2024 Apr;
30(6):1787.
PMID: 38649781
No abstract available.
10.
Lam K, Kamiya-Matsuoka C, Slopis J, McCutcheon I, Majd N
JCO Precis Oncol
. 2024 Feb;
8:e2300442.
PMID: 38394467
Purpose: The purpose of this article was to provide an overview of syndromic gliomas. Design: The authors conducted a nonsystematic literature review. Results: Cancer predisposition syndromes (CPSs) are genetic conditions...